Table 1 Baseline characteristics of the included women (n = 58)
Controls (n = 18) | SG (n = 20) | RYGB (n = 20) | |
|---|---|---|---|
Age (years) | 52 ± 7 | 46 ± 9 | 48 ± 8 |
Body mass index (kg/m2) | 42 ± 6 | 43 ± 4 | 47 ± 6*† |
Excess body weight (kg) | 42 ± 15 | 45 ± 11 | 57 ± 17*† |
Waist circumference (cm) | 118 ± 13 | 119 ± 9 | 133 ± 13*† |
Systolic blood pressure (mmHg) | 146 ± 20 | 146 ± 24 | 139 ± 19 |
Diastolic blood pressure (mmHg) | 92 ± 15 | 87 ± 13 | 87 ± 12 |
Total cholesterol (mg/dL) | 204 ± 34 | 210 ± 51 | 201 ± 30 |
HDL-cholesterol (mg/dL) | 48 ± 11 | 49 ± 14 | 47 ± 7 |
LDL-cholesterol (mg/dL) | 129 ± 28 | 132 ± 44 | 125 ± 26 |
oxLDL (mg/dL) | 53 ± 7 | 54 ± 16 | 59 ± 12 |
ApoA1 (mg/dL) | 159 ± 21 | 156 ± 28 | 159 ± 26 |
ApoB (mg/dL) | 105 ± 13 | 110 ± 25 | 108 ± 22 |
Lp(a) (mg/dL) | 38 ± 59 | 43 ± 64 | 40 ± 39 |
Triglycerides (mg/dL) | 135 ± 51 | 153 ± 88 | 136 ± 61 |
Diabetes mellitus | 4 (22%) | 5 (25%) | 5 (25%) |
Oral antidiabetic drugs | 4 (22%) | 4 (20%) | 5 (25%) |
Dyslipidemia | 8 (44%) | 4 (20%) | 7 (35%) |
Statins | 3 (16%) | 1 (4%) | 7 (35%)*† |
Hypertension | 9 (50%) | 12 (60%) | 13 (65%) |
Antihypertensive drugs | 7 (37%) | 12 (60%) | 13 (65%) |
Smokers | 5 (28%) | 7 (35%) | 7 (35%) |